Loading clinical trials...

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia. | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00545207

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.

This 2 arm study will compare the effect of oral Bonviva (150mg, monthly) and placebo on parameters of bone micro-architecture, assessed by CT scan, bone turnover and bone mineral density. Patients wi...

Lead sponsor: Hoffmann-La Roche•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 4

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

NCT00129623 · Post-Menopausal Osteopenia

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 26, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment150

Start date—

Last updatedJan 26, 2017

Condition

Post-Menopausal Osteopenia

Locations shown

Lyon

Paris

Saint-Priest-en-Jarez

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 26, 2017Data synced to Clareo: July 12, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions